Income Statement - Monte Rosa Therapeutics, Inc. (GLUE)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 123.67 | 75.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of revenue | 8.36 | 8.12 | 6.22 | 8.56 | 2.13 | 0.54 | 0.07 |
| Gross profit | 115.32 | 67.50 | -6.22 | -8.56 | -2.13 | -0.54 | -0.07 |
| Total operating expenses | 169.52 | 148.61 | 137.09 | 112.38 | 72.88 | 27.47 | 7.99 |
| Operating income | -54.21 | -81.11 | -143.31 | -112.38 | -72.88 | -28.01 | -7.99 |
| Non-operating income (net) | 14.49 | 10.98 | 8.30 | 3.88 | -1.08 | -7.87 | 0.25 |
| Income before tax | -39.72 | -70.13 | -135.01 | -108.50 | -73.96 | -35.88 | -7.74 |
| Income tax expense | -1.10 | 2.57 | 0.34 | -3.88 | -2.02 | 0.19 | 0.28 |
| Net income | -38.63 | -72.70 | -135.35 | -108.50 | -73.96 | -35.88 | -8.02 |
Show Quarterly Income Statement
Income Statement - Monte Rosa Therapeutics, Inc. (GLUE)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.21 | 2.78 | 12.77 | 23.19 | 84.93 | 60.65 | 9.22 | 4.70 | 1.06 | 8.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of revenue | 2.03 | 2.09 | 2.10 | 2.13 | 2.06 | 2.10 | 2.06 | 1.90 | 1.85 | 1.83 | 1.39 | 1.15 | 2.68 | 2.58 | 2.17 | 1.13 | 0.81 | 0.58 | 0.47 | 0.27 | |||||
| Gross profit | 2.18 | 2.78 | 12.77 | 23.19 | 84.93 | 60.65 | 9.22 | 2.64 | -0.83 | -1.85 | -1.83 | -1.39 | -1.15 | -2.68 | -2.58 | -2.17 | -1.13 | -0.81 | -0.58 | -0.47 | -0.27 | ||||
| Total operating expenses | 52.22 | 52.50 | 45.74 | 38.75 | 40.89 | 47.64 | 35.74 | 35.28 | 34.11 | 34.86 | 36.97 | 37.22 | 34.26 | 32.49 | 28.36 | 27.23 | 24.30 | 23.39 | 19.87 | 18.12 | 11.50 | 11.94 | 6.39 | 5.40 | 4.29 |
| Operating income | -50.03 | -49.72 | -32.98 | -15.55 | 44.04 | 13.00 | -26.53 | -32.64 | -34.95 | -34.86 | -36.97 | -37.22 | -34.26 | -32.49 | -28.36 | -27.23 | -24.30 | -23.39 | -19.87 | -18.12 | -11.50 | -11.94 | -6.39 | -5.40 | -4.29 |
| Non-operating income (net) | 5.58 | 3.64 | 2.72 | 4.46 | 3.67 | 2.60 | 2.74 | 2.58 | 3.06 | 1.59 | 2.26 | 2.23 | 2.22 | 1.71 | 1.04 | 0.76 | 0.37 | -0.05 | 0.03 | -0.28 | -0.77 | -7.72 | -0.17 | 0.03 | -0.01 |
| Income before tax | -44.45 | -46.08 | -30.26 | -11.10 | 47.71 | 15.60 | -23.79 | -30.06 | -31.89 | -33.27 | -34.71 | -34.99 | -32.04 | -30.78 | -27.32 | -26.47 | -23.93 | -23.44 | -19.84 | -18.41 | -12.28 | -19.66 | -6.56 | -5.36 | -4.30 |
| Income tax expense | 0.05 | 0.06 | -3.18 | 1.20 | 0.82 | 2.16 | 0.07 | 0.25 | 0.08 | -0.02 | 0.17 | 0.19 | -2.22 | -1.71 | -1.04 | -0.76 | -0.37 | -0.76 | -0.61 | 0.28 | -0.19 | 0.04 | 0.17 | -0.03 | 0.00 |
| Net income | -44.50 | -46.14 | -27.08 | -12.30 | 46.89 | 13.44 | -23.86 | -30.31 | -31.97 | -33.25 | -34.88 | -35.18 | -32.04 | -30.78 | -27.32 | -26.47 | -23.93 | -23.44 | -19.84 | -18.41 | -12.28 | -19.66 | -6.56 | -5.36 | -4.30 |